[December 04, 2017] |
|
Global Point of Care Testing Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024 - Research and Markets
The "Global
Point of Care Testing Market: Analysis, Companies Profiles, Size, Share,
Growth, Trends and Forecast to 2024" report has been added to Research
and Markets' offering.
The Global Point of Care Testing Market is accounted to reach USD 35.3
billion by 2024 from USD 18.6 billion in 2016; it is growing at a CAGR
of 8.4% in the forecast period 2017 to 2024.
The major factors driving the market for Global Point-Of-Care Testing
Market, such as increasing geriatric population, increase in infectious
diseases (hepatitis, HIV infection, influenza, respiratory infections
and others), technological advancements, introduction of home-based
point of care devices, and rapid economic development in the emerging
economies.
Scope of the Report
-
The global point-of-care testing market is segmented on the basis of
product into prescription mode, distribution channel, end user, and
geography.
-
On the basis of product, the market is segmented into 13 major
segments, which includes blood glucose testing kits, cardio metabolic
monitoring kits, infectious disease testing kits, cholesterol testing
kits, pregnancy and fertility tests kits, tumor/cancer markers,
urinalysis teting kits, cholesterol test strips, hematology testing
kits, drugs of abuse testing kits, fecal occult testing kits, rapid
coagulation testing kits, and others.
-
Cardiometabolic Monitoring Kits are further segmented into cardiac
markers, blood gas/electrolytes testing kits, HbA1c testing kits, and
lipids testing.
-
Also, infectious disease testing kits are further segmented into
influenza testing kits, HIV testing kits, hepatitis C testing kits,
sexually-transmitted diseases testing kits, tropical diseases testing
kits, healthcare-associated infections), and respiratory infections
testing kit.
-
Based on prescription mode, the global point-of-care testing market is
segmented into prescription based testing and over-the-counter (OTC)
testing.
-
On the basis of distribution channel, the market is segmented into
direct tenders and retail. In 2017, the direct tender market is
expected to dominate the market with a share of 64.0% in the forecast
period 2017-2024.
-
On the basis of end users, the market is segmented into hospital,
clinics, ambulatory care, home healthcare, and research laboratory.
The key market players for Global Point of Care Testing Market
are listed below:
-
Siemens (News - Alert) AG and Abbott Laboratories, Inc.
-
Beckman Coulter, Inc.
-
Becton, Dickinson and Company
-
Johnson & Johnson
-
Alere Inc.
-
Instrumentation Laboratory
-
PTS Diagnostics
-
Abaxis, Inc.
-
Medtronic
-
Accriva Diagnostics
-
OPTI Medical
-
Sienco, Inc.
-
Alpha Scientific
-
AccuBioTech Co., Ltd.
-
ACON Laboratories, Inc.
-
Acrongenomics, Inc.
-
bioMrieux SA
-
Biomerica, Inc.
-
Atlas Genetics Ltd.
-
Alfa Scientific Designs, Inc.
-
Bio-Rad Laboratories, Inc.
-
Medica Corporation
-
Nova Biomedica.
For more information about this report visit https://www.researchandmarkets.com/research/j55tfg/global_point_of
View source version on businesswire.com: http://www.businesswire.com/news/home/20171204005895/en/
[ Back To TMCnet.com's Homepage ]
|